
Specialty pharmaceutical company medac has moved its planners onto a single demand plan. PwC and medac present the rollout and the road ahead at the OMP Conference in Singapore on October 15, 2026.
OMP and PwC have formed an alliance to bring unified, faster supply chain decisions to process manufacturers in life sciences, consumer goods, and chemicals. Planning in these industries runs on campaign production, long lead times, and regulatory requirements, all surfacing “too late to act on” when planning sits in separate systems. The alliance combines Unison Planning™, OMP's AI-enabled planning platform with built-in industry expertise, and PwC's implementation services.
German specialty pharmaceutical company medac is already live under the alliance, with its planners working on a single demand plan in Unison Planning™. PwC and medac will present the project on October 15, 2026, at the OMP Conference in Singapore, detailing the approach behind the rollout and what it means for planning in pharma.
OMP and PwC run each implementation as a single program. OMP brings Unison Planning™, its AI-enabled platform with built-in industry expertise, connecting to the systems that a manufacturer already runs. PwC’s teams lead the implementation, acting as system integrator and working directly alongside the customer's own planners.
Both organizations see the same shift across life sciences, consumer goods, and chemicals: manufacturers replacing fragmented planning with a unified end-to-end plan, and looking for a platform and an implementation team that already know their industry.
"Process manufacturers face the same planning constraints, whatever their size, and few have spare program capacity to absorb an implementation. That is where the combination of the platform, the industry knowledge, and an integrator who can run the program matters most," said Dieter Sleeuwaert, Senior Vice President Global Alliances at OMP.
medac supplies specialty treatments in rheumatology, urology, hematology, and oncology to more than 90 countries, manufacturing at its own European sites. Its planning ran on a mix of spreadsheets, planning functions within its existing ERP system, and a separate tool with limited planning capability. Processes also differed by department and by geography.
PwC, medac and OMP started with a focused demand planning release, resulting in an accelerated go-live for German planners ahead of the wider rollout. The remaining geographies, a supply planning layer, and a second release running in parallel with medac's SAP S/4 implementation will follow.
"Leading with the demand planning release and holding the solution close to standard is what made it work. That approach transfers to other companies in the sector," said Jörg Zietz, Director, Supply Chain Planning at PwC Germany.
The medac Group is committed to improving patients’ quality of life worldwide by providing access to the best possible medical therapies. As a globally operating pharmaceutical company headquartered in Germany, we are active in more than 90 countries and employ over 2,000 people worldwide. With production sites in Europe and a focus on rheumatology, urology, hematology, and oncology, medac develops and markets high-quality originator products, generics, and biosimilars.
OMP helps companies facing complex planning challenges to excel, grow, and thrive by offering the best digitized supply chain planning solution on the market. Hundreds of customers in a wide range of industries - spanning consumer goods, life sciences, chemicals, metals, paper, and packaging - benefit from using OMP's unique Unison Planning™.